Holen Sie sich die Stockscreener-App
90.61
0.19%
0.17
Handel nachbörslich:
90.64
0.03
+0.03%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$90.44
Offen:
$90.715
24-Stunden-Volumen:
3.77M
Relative Volume:
0.64
Marktkapitalisierung:
$72.51B
Einnahmen:
$20.80B
Nettoeinkommen (Verlust:
$2.22B
KGV:
35.16
EPS:
2.5772
Netto-Cashflow:
$3.77B
1W Leistung:
+2.81%
1M Leistung:
+10.03%
6M Leistung:
+11.96%
1J Leistung:
-0.32%
1-Tages-Spanne:
$90.54
$91.52
1-Wochen-Bereich:
$88.36
$91.52
52-Wochen-Spanne:
$74.55
$99.33
Colgate Palmolive Co Stock (CL) Company Profile
Firmenname
Colgate Palmolive Co
Sektor
Telefon
(212) 310-2000
Adresse
300 PARK AVE, NEW YORK, NY
Compare CL vs PG, UL, KVUE, KMB
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CL
Colgate Palmolive Co
|
90.61 | 72.37B | 20.80B | 2.22B | 3.77B | 2.5772 |
PG
Procter Gamble Co
|
144.44 | 333.92B | 86.72B | 16.69B | 15.03B | 6.8375 |
UL
Unilever Plc Adr
|
57.35 | 125.38B | 56.67B | 6.96B | 7.39B | 3.1265 |
KVUE
Kenvue Inc
|
17.53 | 33.52B | 15.29B | 1.62B | 1.82B | 0.8433 |
KMB
Kimberly Clark Corp
|
99.14 | 32.77B | 16.56B | 1.75B | 1.84B | 6.36 |
Colgate Palmolive Co Stock (CL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-21 | Hochstufung | Rothschild & Co Redburn | Neutral → Buy |
| 2026-03-31 | Herabstufung | TD Cowen | Buy → Hold |
| 2026-03-30 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2026-01-13 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2026-01-07 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2025-12-11 | Herabstufung | Argus | Buy → Hold |
| 2025-12-09 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2025-10-03 | Fortgesetzt | Piper Sandler | Neutral |
| 2024-10-28 | Herabstufung | Stifel | Buy → Hold |
| 2024-09-24 | Eingeleitet | Piper Sandler | Overweight |
| 2024-09-16 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2024-09-09 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2024-07-26 | Herabstufung | HSBC Securities | Buy → Hold |
| 2024-07-24 | Herabstufung | Jefferies | Buy → Hold |
| 2024-07-23 | Eingeleitet | TD Cowen | Buy |
| 2024-06-24 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2024-03-01 | Fortgesetzt | Goldman | Buy |
| 2024-01-29 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2023-12-15 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-11-13 | Eingeleitet | Jefferies | Buy |
| 2023-10-16 | Hochstufung | Stifel | Hold → Buy |
| 2023-09-22 | Eingeleitet | HSBC Securities | Buy |
| 2023-02-17 | Eingeleitet | Citigroup | Buy |
| 2023-01-30 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-11-22 | Eingeleitet | Wolfe Research | Peer Perform |
| 2022-10-13 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2022-08-01 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2022-05-03 | Herabstufung | Atlantic Equities | Overweight → Neutral |
| 2022-04-08 | Eingeleitet | Raymond James | Mkt Perform |
| 2022-02-02 | Hochstufung | Bernstein | Underperform → Mkt Perform |
| 2022-01-31 | Bestätigt | Citigroup | Neutral |
| 2022-01-31 | Bestätigt | Credit Suisse | Outperform |
| 2022-01-31 | Bestätigt | Deutsche Bank | Buy |
| 2022-01-31 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2022-01-31 | Bestätigt | Wells Fargo | Underweight |
| 2021-12-16 | Eingeleitet | Redburn | Neutral |
| 2021-10-05 | Fortgesetzt | BofA Securities | Neutral |
| 2021-09-20 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2021-06-24 | Eingeleitet | UBS | Buy |
| 2021-06-09 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2021-02-01 | Hochstufung | Credit Suisse | Underperform → Neutral |
| 2021-01-28 | Herabstufung | Stifel | Buy → Hold |
| 2021-01-26 | Hochstufung | Berenberg | Sell → Hold |
| 2021-01-20 | Eingeleitet | Bernstein | Underperform |
| 2021-01-04 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-12-08 | Eingeleitet | Wells Fargo | Underweight |
| 2020-07-22 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-03-27 | Hochstufung | Stifel | Hold → Buy |
| 2020-03-27 | Hochstufung | SunTrust | Hold → Buy |
| 2020-03-23 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-03-20 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2020-02-03 | Hochstufung | Atlantic Equities | Neutral → Overweight |
| 2020-02-03 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2019-12-19 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2019-10-16 | Eingeleitet | Berenberg | Sell |
| 2019-04-29 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2019-03-07 | Eingeleitet | Credit Suisse | Underperform |
| 2019-02-11 | Hochstufung | Exane BNP Paribas | Underperform → Neutral |
| 2019-01-11 | Eingeleitet | Evercore ISI | Outperform |
| 2019-01-09 | Hochstufung | Goldman | Neutral → Buy |
| 2018-10-29 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2018-10-26 | Herabstufung | SunTrust | Buy → Hold |
| 2018-07-30 | Herabstufung | Macquarie | Outperform → Neutral |
| 2018-05-25 | Hochstufung | Argus | Hold → Buy |
| 2018-04-30 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
Alle ansehen
Colgate Palmolive Co Aktie (CL) Neueste Nachrichten
Colgate FY26 Net Profit Declines to Rs 1,325.31 Cr - scanx.trade
Colgate-Palmolive India leans on premium products, advertising to drive growth - The Economic Times
Colgate Q4 FY26 Net Sales Rise 9%; Declares Dividend - scanx.trade
Colgate-Palmolive India Q4 profit down marginally to Rs 353 cr; FY26 revenue dips to Rs 6,124 cr - The Economic Times
Colgate Palmolive India's quarterly adjusted profit rises on demand for premium products - Reuters
Rathbones Group PLC Increases Stock Position in Colgate-Palmolive Company $CL - MarketBeat
PNC Financial Services Group Inc. Sells 62,956 Shares of Colgate-Palmolive Company $CL - MarketBeat
Household Cleaning Products Market is expected to Hit US$ 65.2 - openPR.com
HighTower Advisors LLC Cuts Stock Holdings in Colgate-Palmolive Company $CL - MarketBeat
Colgate-Palmolive Co stock (US1845021021): strong Q1 momentum and raised outlook draw investor focus - AD HOC NEWS
Colgate-Palmolive execs speak at global consumer conference in Paris - Stock Titan
Is CL Overvalued? DCF Says Worth $43 - GuruFocus
3 Stocks With Rare Bearish Price Targets From Wall Street Analysts (CL, FCEL, FHI)News and Statistics - IndexBox
Global Oral Care Market Outlook 2026-2036: Daily Replenishment Demand and Premiumization Drive Growth for Colgate-Palmolive, Procter & Gamble, and Unilever - PR Newswire UK
AMF Tjanstepension AB Trims Stock Position in Colgate-Palmolive Company $CL - MarketBeat
Oil Prices Surge Amid U.S.-Iran Tensions and Low Global Stocks - GuruFocus
Colgate Palmolive (CL) EVP sells 2,300 shares at $88.44 - Stock Titan
Colgate-Palmolive Co (CL) Stock Price, Trades & News - GuruFocus
Colgate-Palmolive May Be Boring, But CL Stock Has Great Upside Potential Here - Barchart.com
Blume Capital Management Inc. Purchases 20,380 Shares of Colgate-Palmolive Company $CL - MarketBeat
CL Technical Analysis | Trend, Signals & Chart Patterns | COLGATE-PALMOLIVE CO (NYSE:CL) - ChartMill
Colgate’s ‘Every Smile Has a Story’ Shares Family Moments From Across Asia-Pacific - Branding in Asia
What is Zacks Research's Forecast for CL Q2 Earnings? - MarketBeat
Oil Prices Rise Amid Escalating Middle East Tensions - GuruFocus
Colgate-Palmolive Co stock (US1845021021): solid growth and guidance debate after latest earnings - AD HOC NEWS
Consumer Staples Stocks Analysis – Coty, Colgate-Palmolive, Philip Morris (May 2026)News and Statistics - IndexBox
The Dividend Stock That Keeps Raising Its Payout No Matter What the Market Does - The Motley Fool
Canada Post Corp Registered Pension Plan Has $6.02 Million Stake in Colgate-Palmolive Company $CL - MarketBeat
Accredited Investors Inc. Acquires Shares of 11,953 Colgate-Palmolive Company $CL - MarketBeat
CL Stock Price and Chart — NYSE:CL - TradingView
Colgate-Palmolive (CL) Beats Expectations as Analysts Raise Price Targets - Insider Monkey
Why Colgate's Innovation Strategy Is Fueling Market Share Gains - Yahoo Finance UK
BNY Mellon Dynamic Value Fund's Colgate-Palmolive Co(CL) Holding History - GuruFocus
Top Colgate-Palmolive (CL) Competitors 2026 - MarketBeat
Colgate-Palmolive (CL): The Best Stock to Buy in Falling Markets According to Wall Street Analysts - Insider Monkey
Oil Prices Drop as Vessels Navigate Hormuz Strait - GuruFocus
CL Stock Chart | COLGATE-PALMOLIVE CO (NYSE:CL) - ChartMill
Colgate-Palmolive (India) stock (INE259A01022): Steady performer in India's oral care market - AD HOC NEWS
Colgate-Palmolive (CL) Announces Results of Annual Stockholders Meeting - GuruFocus
Director at Colgate-Palmolive (NYSE: CL) receives stock and option awards - Stock Titan
Colgate-Palmolive (CL) director Newman granted shares and options in annual equity awards - Stock Titan
Colgate-Palmolive (CL) director receives stock grant and 2,424-share option award - Stock Titan
Colgate-Palmolive (NYSE: CL) director awarded new stock and options - Stock Titan
Director at Colgate (NYSE: CL) receives stock grant and options - Stock Titan
Colgate-Palmolive (CL) director awarded shares and 2,424 stock options - Stock Titan
Colgate (NYSE: CL) director John Cahill receives stock and option grants - Stock Titan
Colgate-Palmolive (CL) director John Bilbrey receives stock grant and options - Stock Titan
Colgate-Palmolive (CL) holders reject DEI, chair proposals but approve pay - Stock Titan
CL DCF Analysis: Intrinsic Value $43 vs Price $87 - GuruFocus
‘Clockworks’ development plan unveiled for former Colgate site in Clarksville - Louisville Public Media
Dettol bar soap packaging claims challenged by Colgate-Palmolive - thepost.co.za
Finanzdaten der Colgate Palmolive Co-Aktie (CL)
Umsatz
Nettogewinn
Free Cashflow
ENV
Colgate Palmolive Co-Aktie (CL) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Massey Sally | Chief People Officer |
May 07 '26 |
Sale |
87.41 |
8,599 |
751,633 |
13,785 |
| Tsourapas Panagiotis | COO, Eur., APac, Afr Eur, Skin |
Feb 11 '26 |
Option Exercise |
76.41 |
35,000 |
2,674,350 |
45,415 |
| Tsourapas Panagiotis | COO, Eur., APac, Afr Eur, Skin |
Feb 12 '26 |
Option Exercise |
76.41 |
15,000 |
1,146,150 |
25,415 |
| Tsourapas Panagiotis | COO, Eur., APac, Afr Eur, Skin |
Feb 11 '26 |
Sale |
94.61 |
35,000 |
3,311,326 |
10,415 |
| Tsourapas Panagiotis | COO, Eur., APac, Afr Eur, Skin |
Feb 12 '26 |
Sale |
97.81 |
15,000 |
1,467,111 |
10,415 |
0.40%
0.64%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):